NT_1170x120_1-11-18

Pfizer Consumer Healthcare

Pfizer to organize into three businesses for future growth

Pfizer to organize into three businesses for future growth

NEW YORK — Pfizer Inc. announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables; an off-patent branded and generic Established Medicines business operating with substantial autonomy within Pfizer and a Consumer Healthcare business. These

GSK to buy out Novartis in consumer health joint venture

GSK to buy out Novartis in consumer health joint venture

LONDON and BASEL, Switzerland — GlaxoSmithKline plc plans to buy Novartis’ 36.5% stake in their consumer health care joint venture for $13 billion. Under the agreement announced Tuesday, Novartis’ shares in the joint venture will be canceled, and the joint venture will pay the buyout price to Novartis. GSK has entered into a committed facilities agreement to

Aurobindo releases Nexium 24HR generic

Aurobindo releases Nexium 24HR generic

HYDERABAD, India — Aurobindo Pharma Ltd. has received Food and Drug Administration approval to manufacture over-the-counter 20-mg esomeprazole magnesium delayed-release capsules, an antacid. Aurobindo said its esomeprazole OTC product, being shipped immediately, is a generic version of Nexium 24HR capsules from Pfizer Consumer Healthcare. A proton pump inhibitor (PPI), Nexium 24HR capsules are indicated for

Gelbert joins Nature’s Bounty as chief scientific officer

Gelbert joins Nature’s Bounty as chief scientific officer

RONKONKOMA, N.Y. — Former Pfizer executive Mark Gelbert has been named chief scientific officer of The Nature’s Bounty Co. Gelbert will lead Nature’s Bounty’s research, development and innovation efforts by creating and executing product development strategies, enhancing product offerings, and driving product advancements across all of its global brands. “I am thrilled to be joining

Pfizer mulls possible sale of consumer health unit

Pfizer mulls possible sale of consumer health unit

NEW YORK — Pfizer Inc. is assessing strategic options for its Pfizer Consumer Healthcare subsidiary, including a potential sale. The pharmaceutical giant said this week that it’s considering “a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.” However, the company noted that it may decided

Centrum VitaMints offer refreshing multivitamin option

Centrum VitaMints offer refreshing multivitamin option

MADISON, N.J. — Centrum is providing a more flavorful and convenient way to take a multivitamin. The Pfizer Consumer Healthcare brand has launched Centrum VitaMints, a minty, chewable multivitamin. The company said the new multivitamin, which has a cool mint flavor, can be enjoyed like a mint and taken on the go, with or without

Caltrate adds 3-in-1 Bone & Joint Health supplement to lineup

Caltrate adds 3-in-1 Bone & Joint Health supplement to lineup

MADISON, N.J. — Pfizer Consumer Healthcare has rolled out Caltrate Bone & Joint Health, described as a triple-action supplement to promote bone health. Pfizer said Tuesday that the once-daily Caltrate Bone & Joint Health, now available exclusively at Walgreens, provides three benefits in one supplement: UC-II, an exclusive form of collagen, to support healthy cartilage

Centrum unveils gummy multivitamin

Centrum unveils gummy multivitamin

MADISON, N.J. — Pfizer Consumer Healthcare has launched Centrum MultiGummies, a multivitamin that comes in an easier-to-take, pleasant-tasting gummy form. Centrum MultiGummies include key nutrients such as vitamins D, B12 and E and come in natural flavors, including berry, cherry and orange. The product also is gluten-free, contains only natural colorants and has no artificial sweeteners. Pfizer said Thursday that Centrum MultiGummies offer a more appealing